Cantourage Group SE (ETR:HIGH)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceuticals	3.91M	2.20M	1.66M	603.31K	5.22M
Pharmaceuticals Growth	77.97%	32.06%	175.55%	-88.43%	-
Total	3.91M	2.20M	1.66M	603.31K	5.22M
Total Growth	77.97%	32.06%	175.55%	-88.43%	-

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Germany	3.91M	2.20M	1.66M	603.31K	5.22M
Germany Growth	77.97%	32.06%	175.55%	-88.43%	-
Total	3.91M	2.20M	1.66M	603.31K	5.22M
Total Growth	77.97%	32.06%	175.55%	-88.43%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 12, 2026

Data Sources Report a data error